These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23881880)

  • 21. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.
    Schifano F; Papanti GD; Orsolini L; Corkery JM
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):943-54. PubMed ID: 26985969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
    Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
    Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance use in the club scene of Rome: a pilot study.
    Vento AE; Martinotti G; Cinosi E; Lupi M; Acciavatti T; Carrus D; Santacroce R; Chillemi E; Bonifaci L; di Giannantonio M; Corazza O; Schifano F
    Biomed Res Int; 2014; 2014():617546. PubMed ID: 25243163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016.
    Deen AA; Claridge H; Treble RD; Hamnett HJ; Copeland CS
    J Psychopharmacol; 2021 Nov; 35(11):1315-1323. PubMed ID: 34182812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel psychoactive substance and other drug use by young adults in Western australia.
    Goggin LS; Gately N; Bridle RI
    J Psychoactive Drugs; 2015; 47(2):140-8. PubMed ID: 25950594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Professional drivers and psychoactive substances consumption: results from medical surveillance at the workplace in Piedmont region].
    Rosso GL; Feola M; Rubinetto MP; Petti N; Rubinetto L
    G Ital Med Lav Ergon; 2011; 33(3 Suppl):203-6. PubMed ID: 23393836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective observational study of emergency department presentations following novel psychoactive substance use.
    Henshall DE; Innes CW; Morrison SR; Wilson B; Brown RA; McAllister SM; Culshaw SL; Reda E
    Scott Med J; 2018 May; 63(2):39-44. PubMed ID: 29514583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Internet and psychoactive substance use among innovative drug users.
    Boyer EW; Shannon M; Hibberd PL
    Pediatrics; 2005 Feb; 115(2):302-5. PubMed ID: 15687436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring novel psychoactive substances allegedly offered online for sale in Persian and Arabic languages.
    Corazza O; Assi S; Malekianragheb S; Beni MN; Bigdeli I; Aslanpour Z; Schifano F
    Int J Drug Policy; 2014 Jul; 25(4):724-6. PubMed ID: 24917190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Legal highs": safe and legal "heavens"? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK.
    Corazza O; Simonato P; Corkery J; Trincas G; Schifano F
    Riv Psichiatr; 2014; 49(2):89-94. PubMed ID: 24770577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The challenge of complex drug use: Associated use of codeine-containing medicines and new psychoactive substances in a European cross-sectional online population.
    Kimergård A; Foley M; Davey Z; Wadsworth E; Drummond C; Deluca P
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders.
    Dal Farra D; Valdesalici A; Zecchinato G; De Sandre A; Saccon D; Simonato P; Corazza O; Martinotti G; Smith AL; Solmi M
    Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting.
    Smith CD; Robert S
    Clin Med (Lond); 2014 Aug; 14(4):409-15. PubMed ID: 25099844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs on the web; the Psychonaut 2002 EU project.
    Schifano F; Deluca P; Baldacchino A; Peltoniemi T; Scherbaum N; Torrens M; Farre M; Flores I; Rossi M; Eastwood D; Guionnet C; Rawaf S; Agosti L; Di Furia L; Brigada R; Majava A; Siemann H; Leoni M; Tomasin A; Rovetto F; Ghodse AH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):640-6. PubMed ID: 16458404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP).
    Wood DM; Dargan PI
    Clin Toxicol (Phila); 2012 Sep; 50(8):727-32. PubMed ID: 22882169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.
    Deligianni E; Daniel OJ; Corkery JM; Schifano F; Lione LA
    Br J Clin Pharmacol; 2020 Mar; 86(3):505-516. PubMed ID: 31495968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA).
    Weber C; Smith JL; Soderstrom J; Burrows S; McCutcheon D; Oosthuizen F; Fatovich DM;
    Clin Toxicol (Phila); 2023 Jul; 61(7):500-508. PubMed ID: 37449677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Legal highs toxicity--symptomatology and clinical diagnosis in case series.
    Łukasik-Głebock M; Sommerfeld K; Nawrocka K
    Przegl Lek; 2010; 67(8):613-6. PubMed ID: 21384787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review.
    Orsolini L; Chiappini S; Corkery JM; Guirguis A; Papanti D; Schifano F
    Expert Rev Neurother; 2019 Dec; 19(12):1253-1264. PubMed ID: 31503507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.